About Motaz Qadan, MD, PhD

Watch a video about my work

Motaz Qadan, MD, PhD, is a hepatobiliary and pancreatic surgical oncologist at the Massachusetts General Hospital (MGH). He is a high volume pancreas and liver specialized surgeon with excellent outcomes. Patient information videos about his common operations are included below: 

Dr. Qadan's leadership positions include: 

  • Harvard Medical Student Advanced Surgical Clerkship Director
  • Pancreas Cyst Multidisciplinary Clinic Director
  • Mass General Brigham Resident and Fellow Wellbeing Council Faculty Advisor
  • Complex General Surgical Oncology Fellowship Program Director at the MGH
  • Clinical Lead for Enhanced Recovery after Surgery (ERAS) in Pancreas Surgery

Dr. Qadan received his undergraduate and medical degrees from the University of Edinburgh Medical School, which is among the top medical schools in Western Europe. He completed surgical residency at Stanford University, where he served as administrative chief resident. Following this, he completed a fellowship in complex general surgical oncology at the Memorial Sloan Kettering Cancer Center in New York and served as the educational coordinator during his fellowship.

Dr. Qadan is also a Fellow of the American College of Surgeons (FACS) and a Member of the Royal College of Surgeons of Edinburgh (MRCSEd). He is a surgical member of the multidisciplinary cancer team at the MGH in Boston.

Clinical Interests:

Treats:

Locations

Boston: Massachusetts General Hospital

Department of Surgery
55 Fruit Street
Boston, MA 02114-2696
Phone: 617-643-5153
Fax: 617-724-3895

View location, directions and parking information for Mass General

Medical Education

  • MD, University of Edinburgh
  • PHD, University of Louisville
  • Residency, Stanford University Hospital and Clinics
  • Residency, Stanford University Medical Center
  • Fellowship, Memorial Sloan Kettering Cancer Center

American Board Certifications

  • Surgery, American Board of Surgery
  • Complex General Surgical Oncology, American Board of Surgery

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Research

The Qadan laboratory focuses on the tumor microenvironment in pancreas cancer. Current scientific and translational efforts in his laboratory include the evaluation of the radiosensitizing effects of Losartan and introduction of Fingolimod (sphingosine-1-phosphate receptor 1 antagonist) for endothelial barrier disruption in orthotopic pancreatic tumor models.

Dr. Qadan is also interested in clinical outcomes health services research and leads a large group of researchers who focus on methods to collect, analyze, and improve outcomes related to cancer surgery at the institutional and national level. His projects have earned national recognition in the form of multiple prizes and awards over the last few months.

Dr. Qadan is an active clinical investigator in several high impact clinical trials. He is a principal investigator on a prehabilitation study entitled "Pilot Study of a Multimodal Prehabilitation Pancreatic Cancer Program" where he enrolls patients in an exercise and nutrition program to improve their outcomes during treatment for pancreatic cancer.

Dr. Qadan is actively involved in many National societies including the AHPBA, SSO, SSAT, ALF, and several others. He currently holds active leadership roles in several organizations and has over 120 peer-reviewed scientific articles as well as several book chapters and scientific abstracts. Dr. Qadan is also an active member of the Gastrointestinal Malignancies Program at the Dana-Farber/Harvard Cancer Center. 

If you are interested in making a direct donation to Dr. Qadan's research, please proceed to the "Email Me" link to coordinate delivery of your generous gift.

Publications